Status:
COMPLETED
Primary Tumor Harvest for the Purpose of Possible Use in a Future Clinical Trial in Patients With Ovarian, Fallopian Tube or Primary Peritoneal Cancer
Lead Sponsor:
Beth Israel Deaconess Medical Center
Collaborating Sponsors:
Dana-Farber Cancer Institute
Massachusetts General Hospital
Conditions:
Ovarian Cancer
Peritoneal Cancer
Eligibility:
FEMALE
18+ years
Phase:
NA
Brief Summary
The purpose of this research study is to collect tumor samples at the time of surgery and store them for possible use as part of an experimental vaccine study for the participants cancer in the future...
Detailed Description
* Even if tumor sample is collected, the participant is under no obligation to participate in the vaccine study. * Participants will have their regularly planned surgery as described by their surgeon....
Eligibility Criteria
Inclusion
- Clinical suspicion of advanced ovarian, fallopian tube or primary peritoneal cancer as determined by a gynecologic oncologist
- Patients are planning to undergo primary or secondary debulking surgery as part of standard of care for their disease
- Estimated life expectancy of 6 months or greater
- 18 years of age or older
Exclusion
- More than one prior chemotherapy regimen
- Serious intercurrent illness such as infection requiring IV antibiotics, or significant cardiac disease characterized by significant arrhythmia, unstable ischemic coronary disease or congestive heart failure
- Known HIV infection
- Active second malignancy, aside from basal cell or squamous cell carcinoma of the skin
- Significant autoimmune disease, including psoriasis
- History of clinically significant venous thromboembolism
Key Trial Info
Start Date :
September 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
August 1 2020
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT00801320
Start Date
September 1 2008
End Date
August 1 2020
Last Update
September 10 2020
Active Locations (4)
Enter a location and click search to find clinical trials sorted by distance.
1
Massachusetts General Hospital
Boston, Massachusetts, United States, 02114
2
Brigham & Women's Hospital
Boston, Massachusetts, United States, 02115
3
Dana-Farber Cancer Institute
Boston, Massachusetts, United States, 02115
4
Beth Israel Deaconess Medical Center
Boston, Massachusetts, United States, 02215